Artificial intelligence-driven antimicrobial peptide discovery

• URL: http://arxiv.org/abs/2308.10921v1
• Date: Mon, 21 Aug 2023 14:02:14 GMT
• Title: Artificial intelligence-driven antimicrobial peptide discovery
• Authors: Paulina Szymczak, Ewa Szczurek
• Abstract summary: Antimicrobial peptides (AMPs) emerge as promising agents against antimicrobial resistance. AMPs provide an alternative to conventional antibiotics. Artificial intelligence (AI) revolutionized AMP discovery through both discrimination and generation approaches.
• Score: 0.0
• License: http://creativecommons.org/licenses/by-nc-nd/4.0/
• Abstract: Antimicrobial peptides (AMPs) emerge as promising agents against antimicrobial resistance, providing an alternative to conventional antibiotics. Artificial intelligence (AI) revolutionized AMP discovery through both discrimination and generation approaches. The discriminators aid the identification of promising candidates by predicting key peptide properties such as activity and toxicity, while the generators learn the distribution over peptides and enable sampling novel AMP candidates, either de novo, or as analogues of a prototype peptide. Moreover, the controlled generation of AMPs with desired properties is achieved by discriminator-guided filtering, positive-only learning, latent space sampling, as well as conditional and optimized generation. Here we review recent achievements in AI-driven AMP discovery, highlighting the most exciting directions.

Related papers

• REAL Sampling: Boosting Factuality and Diversity of Open-Ended Generation via Asymptotic Entropy [93.8400683020273]
  Decoding methods for large language models (LLMs) usually struggle with the tradeoff between ensuring factuality and maintaining diversity. We propose REAL sampling, a decoding method that improved factuality and diversity over nucleus sampling.
  arXiv  Detail & Related papers  (2024-06-11T21:44:49Z)
• Regressor-free Molecule Generation to Support Drug Response Prediction [83.25894107956735]
  Conditional generation based on the target IC50 score can obtain a more effective sampling space. Regressor-free guidance combines a diffusion model's score estimation with a regression controller model's gradient based on number labels.
  arXiv  Detail & Related papers  (2024-05-23T13:22:17Z)
• HMAMP: Hypervolume-Driven Multi-Objective Antimicrobial Peptides Design [11.891046340221735]
  This paper introduces a paradigm shift by considering multiple attributes in Antimicrobial peptides (AMPs) design. By synergizing reinforcement learning and a descent algorithm rooted in the hypervolume of AMP concept, HMAMP effectively expands exploration space and mitigates the issue of pattern collapse. A detailed analysis of the helical structures and molecular dynamics simulations for ten potential candidate AMPs validates the superiority of HMAMP in the realm of multi-objective AMP design.
  arXiv  Detail & Related papers  (2024-05-01T07:17:59Z)
• Accelerating Antimicrobial Peptide Discovery with Latent Structure [33.288514128470425]
  We propose a latent sequence-structure model for designing AMPs (LSSAMP) LSSAMP exploits multi-scale vector quantization in the latent space to represent secondary structures. Experimental results show that the peptides generated by LSSAMP have a high probability of antimicrobial activity.
  arXiv  Detail & Related papers  (2022-11-28T06:43:32Z)
• Graph-Based Active Machine Learning Method for Diverse and Novel Antimicrobial Peptides Generation and Selection [57.131117785001194]
  Large-scale screening of new AMP candidates is expensive, time-consuming, and now affordable in developing countries. We propose a novel active machine learning-based framework that statistically minimizes the number of wet-lab experiments needed to design new AMPs.
  arXiv  Detail & Related papers  (2022-09-18T14:30:48Z)
• Diversifying Design of Nucleic Acid Aptamers Using Unsupervised Machine Learning [54.247560894146105]
  Inverse design of short single-stranded RNA and DNA sequences (aptamers) is the task of finding sequences that satisfy a set of desired criteria. We propose to use an unsupervised machine learning model known as the Potts model to discover new, useful sequences with controllable sequence diversity.
  arXiv  Detail & Related papers  (2022-08-10T13:30:58Z)
• HMD-AMP: Protein Language-Powered Hierarchical Multi-label Deep Forest for Annotating Antimicrobial Peptides [5.61222966894307]
  We build a diverse and comprehensive multi-label protein sequence database by collecting and cleaning amino acids from various AMP databases. We develop an end-to-end hierarchical multi-label deep forest framework, HMD-AMP, to annotate AMP comprehensively. After identifying an AMP, it further predicts what targets the AMP can effectively kill from eleven available classes.
  arXiv  Detail & Related papers  (2021-11-11T02:10:07Z)
• Accelerating Antimicrobial Discovery with Controllable Deep Generative Models and Molecular Dynamics [109.70543391923344]
  CLaSS (Controlled Latent attribute Space Sampling) is an efficient computational method for attribute-controlled generation of molecules. We screen the generated molecules for additional key attributes by using deep learning classifiers in conjunction with novel features derived from atomistic simulations. The proposed approach is demonstrated for designing non-toxic antimicrobial peptides (AMPs) with strong broad-spectrum potency.
  arXiv  Detail & Related papers  (2020-05-22T15:57:58Z)
• Unsupervised Anomaly Detection with Adversarial Mirrored AutoEncoders [51.691585766702744]
  We propose a variant of Adversarial Autoencoder which uses a mirrored Wasserstein loss in the discriminator to enforce better semantic-level reconstruction. We put forward an alternative measure of anomaly score to replace the reconstruction-based metric. Our method outperforms the current state-of-the-art methods for anomaly detection on several OOD detection benchmarks.
  arXiv  Detail & Related papers  (2020-03-24T08:26:58Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.